send to a friend by email
The Palestine Exchange (PEX) received the unaudited interim consolidated condensed financial statements from Jerusalem Pharmaceuticals Company ( JPH). PEX disclosure rules give all PEX listed companies one month to report their first quarter interim financial statements as reviewed by the company’s internal auditor. In addition to this press release, this disclosure was published on the PEX website (www.pex.ps) and emailed to PEX member securities firms.
The disclosed information includes: the Statement of Financial Position, the Income Statement, Changes in Equity Ownership and the Statement of Cash Flows. The company also provided its interim financial statements via the approved electronic form of disclosure applicable to the Industry Sector. The interim report should also include information required by Article (37/2) of the PEX disclosure rules in place. The company included information regarding management, issued shares, material changes and significant events that may have affected financial performances during the first three months of the year.
According to company data for the first three months of the year, net loss reached (212,085) JOD, compared with a net profit before taxes of 401,499 JOD from the first three months of 2011. Total assets of the company reached 35,989,436 JOD as of March 31st, 2012, compared to total assets of 35,360,263 JOD as of December 31st, 2011, a net increase of 1.8%. Total liabilities of the company reached 9,843,924 JOD as of March 31st, 2012, compared to total liabilities of 9,204,370 JOD as of December 31st, 2011, a net increase of 6.9%. Net ownership equity of the company reached 26,145,512 JOD (including 336,215 JOD in Minority Rights) as of March 31st, 2012, compared with a net ownership equity of 26,155,893 JOD (including 265,164 JOD in Minority Rights) as of December 31st, 2011, a net decrease of 0.04% in the first three months.